Effects of oral contraceptive pill on female health
Abstract
Oral contraceptives, also known as birth control tablets/pills, are medicines that stop pregnancy. About 75% of married women who use contraception in the research location (Purba Medinipur district) reported they prefer the combined hormonal pill with oestrogen and progesterone. Thirty women were chosen at random to participate in the study. Of the 50% who routinely used contraceptive pills and 50% never used them or occasionally did so. Her male partner likely uses a condom when necessary. The hormone progesterone is responsible for preventing conception, whereas the oestrogen component regulates menstrual blood loss. An questionnaire survey is used in one-on-one interviews. Statistics used in the study were descriptive. To examine the data, an unpaired ‘t’ test was employed. In order to provide effective contraception using oral contraceptives, this study investigates the adverse effects of oral contraceptive pills. It highlights the significance of better care coordination among occupational therapist. According to this study, one of the most common oral contraceptive regimens decreases women's quality of life while not affecting depressive symptoms. However, ovarian and menstrual issues and increased bone mineral density are very noticeable in women in their forties and significantly impact their behaviour. Younger women are more receptive to oral contraceptives' positive benefits on acne. It has been shown that birth control pill side effects can include complications including cystic acne, anxiety or irritability, sore breasts, weight gain, or some trouble conceiving after discontinuing the pill. The study makes predictions about the menstrual flow type, dysmenorrhea, blood pressure, waist-hip ratio, and pattern of contraceptive use. Consuming oral contraceptives is linked to some symptoms, including breast soreness, weight gain, missing periods, vaginal discharge, alterations in vision with contact lenses, and irregular or spotty bleeding.
References
Anahad, O. C. (2013). Birth Control Pills May Raise Eye Risks. Well woman. https://archive.nytimes.com/well.blogs.nytimes.com/2013/11/21/birth-control-pills-may-raise-eye-risks/
Appleby, P., & Beral, V. (2007). Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. International Collaboration of Epidemiological Studies of Cervical Cancer.Lancet. 370(9599):1609–1621.
Centers for Disease Control and Prevention and the National Institute of Child Health and Human Development. (1987). The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. New England Journal of Medicine. 316(11): 650–655.
Chrisman, C.E., & Peterson, H.B. (2002). Contraception forwomen in selected circumstances. Obstetrics Gynecology. 99: 1100–1112.
Elizabeth,W., Loder, Dawn, C., Buse, Joan, R., & Golub. (2005). Headache and Combination Estrogen-Progestin Oral Contraceptives. Integrating Evidence, Guidelines, and Clinical Practice. 45: 224-231.
Frisancho, A.R. (1990). Anthropometric Standards for the Assessment of growth and Nutritional Status. Michigan Publishing, University of Michigan Press. Pp. 1-200. doi: 10.3998/mpub.12198
Gainer, E., Blum, J., Toverud, E. L., Portugal, N., Tyden, T., Nesheim, B. I., & Lutwick, A. (2003). Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal. Contraception. 68(2): 117-124.
Gupta, S. (2000). Weight gain on the combined pill–-is it real?. Human reproduction. Pp.427 - 431.
Hatcher, R.A. and Nelson, A.L. (2004). Combined Hormonal Contraceptive Methods". In Hatcher, Robert D.Contraceptive technology (18th ed.). New York: Ardent Media, Inc. Pp. 403, 432, 434.
Henry, C.J.K. (1990). Body mass index and the limits of human survival. European Journal of Clinical Nutrition. 44: 329-335.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. (2007). Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 91: 74–84.
Jelliffe, D.B. (1966). Assessment of Nutritional Status of the Community. World Health Organization, IRIS report. 34: 156-178.
Jones, J., Mosher, W., & Daniels, K. (2012). Current contraceptive use in the United States, 2006, 2010, and haes in patterns of use since 1995. National health statistics reports, No 60. Hyattsville, MD: National Center for Health Statistics.
LaVecchia, C., & Tavani, A. (2006). Female hormones and benign liver tumours. Digestive and Liver Disease. 38(8): 535–536.
McCann, M.F., & Linda, S.P. (1994). Progestin-only oral contraception: A comprehensive review: X. Common side effects. Contraception. 50(6): S114-S138.
Murayama, N., Matsunaga, A.,Tangbanluekal, L.,Tantawiwat, S., & Ohtsuka, R. (2003). Effects of oral contraceptive use on body mass index and blood pressure among female villagers in north-east Thailand Source. Journal of Biosocial Science. 35(2): 243-261.
Pract, J. F., Patricia A. & Lohr, M.D. (2006). Oral contraceptives and breakthrough bleeding: What patients need to know. The Journal of Family Practice. 55(10): 872-880.
Proctor, M.L., Roberts, H., & Farquahar, C.M. (2001). Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea. Cochrane Database. Syst. Rev. 2001(4): CD002120. doi: 10.1002/14651858.CD002120.
Punnahitananda, S., & Tosukhowong, P. (2000). Effects of the etonogestrel releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those an intrauterine device. Contraception. 62(5): 239–246. doi: 10.1016/s0010-7824(00)00173-6
Radcliffe Infirmary, Oxford Littler, W. A., Bojorges-Bueno, R., & Banks, Judy (1974). Cardiovascular dynamics in women during the menstrual cycle and oral contraceptive therapy W. A. LITTLER, R. BOJORGES-BUENO, and JUDY BANKS The Field Marshal Alexander Department Of Cardiovascular Medicine. Thorax. 29: 567-570.
Shen, Q., Lin, D., Jiang, X., Li, H., & Zhang, Z. (1994). Blood pressure changes and hormonal contraceptives. Contraception. 50(2): 131-41. doi: 10.1016/0010-7824(94)90049-3
Speroff, L. (2005). A clinical guide for contraception (4th ed.). Hagerstown, MD: Lippincott Williams &Wilkins. Pp. 72.
Stephanie, Watson., & Nicole, G.R.N. (2016). Nausea and Birth Control: Why It Happens and How to Prevent It. Stud. Fam Plan. 19: 361–9.
Tanis, B.C., Bosch, M.A.V.D., Kemmeren, J.M., Cats, V.M., Helmerhorst, F.M., Graaf, Y.V.D., & Rosendaal, F.R. (2001). Oral contraceptives and the risk of myocardial infarction. New England Journal Medicine. 345(25): 1787–1793. doi: 10.1056/NEJMoa003216
Thomas, D.B. (1972). Relationship of oral contraceptives to cervical carcinogenesis. Obstetrics & Gynecology. 40(4): 508-518.
Vanphanom, S.,Visanou, H., Alongkone, P., & Keokedthong, P. (2013). Awareness and attitudes towards emergency contraceptive pills among young people in the entertainment places, Vientiane City, Lao PDR. BMC Womens Health. 13: 14. doi: 10.1186/1472-6874-13-14
Waterlow, J.C., Buzina, R.F., & Tanner, S.E. (1990). The presentation and use of height and weight data for comparing the nutritional status. Bull World Health Organ. 55(4): 489-98.
Weir, G. C., DeGroot, L.J., Grossman, A., Marshall J.F., Melmed, S., & Potts, J.T. (2006). Endocrinology (5th ed.). St. Louis, Mo: Elsevier Saunders. Pp. 2999.
Westhoff, C.L., Heartwell, S., Edwards, S., Zieman, M., Stuart, G., Cwiak, C., Davis, A., Robilotto, T., Cushman, L., & Kalmuss, D. (2007). Oral contraceptive discontinuation: do side effects matter?. American Journal Obstetrics and Gynecology. 196(4): 412.
Yu, A. (2014). The effect of oral contraceptive pills and the natural menstrual cycle on arterial stiffness and hemodynamic (CYCLIC). Journal of hypertension. 32(1): 100.
